Who is sponsoring NCT03277287?

NCT03277287 is sponsored by Assiut University.

What drugs are being tested in NCT03277287?

Interventions in NCT03277287: Fractional CO2 laser.

What condition does NCT03277287 study?

NCT03277287 studies Cleft Lip Post-surgical Scar.

Is NCT03277287 still recruiting?

NCT03277287 is currently completed. Last updated 21 April 2020.

Last reviewed 2020-04-21 · How we verify

NCT03277287

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Fractional CO2 Laser in Treatment of Post-surgical Scarring of Cleft Lip

Completed NA Last updated 21 April 2020

What this trial tests

NA trial testing Fractional CO2 laser in Cleft Lip Post-surgical Scar in 120 participants. Completed in 15 February 2020.

Timeline

1 September 2017

Primary endpoint
30 January 2020

15 February 2020

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	treatment
Enrollment	120
Start date	1 September 2017
Primary completion	30 January 2020
Estimated completion	15 February 2020
Sites	1 location across Egypt

Drugs / interventions tested

Fractional CO2 laser

Conditions studied

Cleft Lip Post-surgical Scar — all drugs for Cleft Lip Post-surgical Scar →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Cleft Lip Post-surgical Scar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective comparative study on 120 patients divided to three groups. Group A: 40 patients laser will be applied 3 weeks post-surgical. Group B: 40 patients laser will be applied 3 months post surgical. Group C: 40 patients as a control not treated with laser from 2017 to 2020 which will be conducted on patients with post-surgical cleft lip repair scaring. All patients will have 5-7 sessions with 4 weeks interval. Photographic documentation and evaluation of the scar will occur every 4 weeks.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Use of Fractional CO2 Laser in Cleft Lip Scars: Does It Make a Difference?
Shadad M, Ali WM, Fayyaz GQ, El-Shazly M. · · 2021 · cited 10× · PMID 32826442 · DOI 10.1097/sap.0000000000002511

Verify or expand the search:

Other trials of Fractional CO2 laser

Trials testing the same drug.

NCT07177833 — Title Fractioned CO2 Laser in the Treatment of Chronic Phase Peyronie's Disease · Phase 1 · recruiting
NCT06942468 — Phenytoin in Treatment of Atrophic Post Acne Scars. · Phase 4 · not yet recruiting
NCT06399783 — Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata · Phase 4 · not yet recruiting
NCT06726746 — Efficacy of Fractional CO2 Laser Treatment in Post-Menopausal Women With Vaginal Atrophy · NA · recruiting
NCT05861063 — The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser · Phase 4 · unknown

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03277287 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 21 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03277287.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing